The Covax Facility: Interim Distribution Forecast – Latest as of 3 February 2021
- Author:
- CEPI, Gavi, WHO and UNICEF
- Publisher:
- World Health Organization
- Publication Date:
- 3 February 2021
- Tags:
- Africa, Coronavirus
Building on the publication of the 2021 COVAX global and regional supply forecast, the interim distribution forecast provides information on early projected availability of doses of the Pfizer/BioNTech vaccine in Q1 2021 and the AstraZeneca/Oxford vaccine candidate in first half 2021 to COVAX Facility participants.
COVAX Announces Plan for Global Roll-Out of Covid-19 Vaccines
- Dispatch of Millions of Covid-19 Vaccines to Africa Expected to Start in February - WHO
- Covid-19 Vaccines Could Cement Africa's Relationship With China
- COVAX Publishes First Interim Distribution List
- 'Vaccine Privilege' Could Haunt the West
- Revoke Patents, Defeat the Pandemic & Deliver Global Justice
- Covax Donates 16 Million Doses of Covid-19 Vaccine to Nigeria
- African Countries Scramble for Covid-19 Vaccines
Ensure Covid-19 Vaccine Equity or Face Global Moral Failure - WHO
- Covid-19 'Vaccine Hoarding' Putting Africa At Risk - WHO
- How We Could Overcome the Big Barriers to Global Covid-19 Vaccination
- Continent Lags in Covid-19 Vaccination Drive
- WHO Director-General's Opening Remarks at 148th Session of the Executive Board
- Statement on the 6th Meeting of the IHR (2005) Emergency Committee Regarding the Covid-19 Pandemic
U.S. Urged to Support Waiver of Covid-19 Vaccine Patent Rights
- Should the Biden Administration Help Vaccinate the World Against Covid-19?
- Biden Administration Warned That it is Courting Disaster on Global Covid-19 Vaccines
- How to Get Covid-19 Vaccines to Poor Countries - and Still Keep Patent Benefits for Drugmakers
- 'COVAX is a Smokescreen to Cover Up Vaccine Nationalism'
- The Politics and Promise Behind a Proposed Pandemic Treaty
- Former President of Seychelles Joins Group Asking U.S. to Lift Vaccine Patent Rules
